These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37243499)

  • 1. Public perceptions of medical cannabis diversion: A legal and moral dilemma.
    Ne'eman-Haviv V; Rozmann N
    J Health Psychol; 2023 Nov; 28(13):1264-1275. PubMed ID: 37243499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public perception of guilt and deserved punishment in medical cannabis diversion.
    Rozmann N; Ne'eman-Haviv V
    Drug Alcohol Rev; 2023 Feb; 42(2):304-308. PubMed ID: 36380639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Users of Diverted Medical Cannabis Differ From Other Cannabis Users?
    Tandowski A; Zolotov Y; Sznitman SR
    J Stud Alcohol Drugs; 2019 Jan; 80(1):42-45. PubMed ID: 30807273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term medical cannabis use and risk factors for diversion: Report on physician's guidance and patients' behaviour.
    Sznitman SR; Goldberg V; Sheinman-Yuffe H; Zolotov Y; Flechter E; Bar-Sela G
    Palliat Support Care; 2020 Feb; 18(1):18-23. PubMed ID: 31190678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies.
    Sznitman SR; Bretteville-Jensen AL
    Harm Reduct J; 2015 Oct; 12():46. PubMed ID: 26467203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has the "M" word been framed? Marijuana, cannabis, and public opinion.
    Mikos RA; Kam CD
    PLoS One; 2019; 14(10):e0224289. PubMed ID: 31671110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization?
    Lewis N; Sznitman SR
    Int J Drug Policy; 2019 Nov; 73():219-227. PubMed ID: 30799152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward medical cannabis education in Israel.
    Isralowitz R; Reznik A; Zolotov Y; Grinstein-Cohen O; Wacht O; Pruginin I; Yehudai M; Edelstein O
    Complement Ther Med; 2021 May; 58():102709. PubMed ID: 33716092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
    Leos-Toro C; Shiplo S; Hammond D
    Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal Cannabis: Policy, Patients, and Providers.
    Ryan JE; McCabe SE; Boyd CJ
    Policy Polit Nurs Pract; 2021 May; 22(2):126-133. PubMed ID: 33567970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illegal cannabis use is common among Danes with multiple sclerosis.
    Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
    Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
    Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Public Attitudes Toward Cannabis Legalization: Qualitative Findings From a Statewide Survey.
    Resko S; Ellis J; Early TJ; Szechy KA; Rodriguez B; Agius E
    Subst Use Misuse; 2019; 54(8):1247-1259. PubMed ID: 30999800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey.
    Assanangkornchai S; Thaikla K; Talek M; Saingam D
    PeerJ; 2022; 10():e12809. PubMed ID: 35047242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.
    Lucas P
    Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey.
    Filetti M; Trapani D; Cortellini A; Cofini V; Necozione S; Pinato DJ; Porzio G; Marchetti P; Giusti R
    Support Care Cancer; 2021 Dec; 29(12):7845-7854. PubMed ID: 34176017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles.
    Fedorova EV; Schrager SM; Robinson LF; Cepeda A; Wong CF; Iverson E; Lankenau SE
    Drug Alcohol Depend; 2019 May; 198():21-27. PubMed ID: 30861391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.